New anemia pill for dialysis patients tested against standard shots

NCT ID NCT06901505

Ongoing Disease control Sponsor: Akebia Therapeutics Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new pill, vadadustat, taken three times a week, against the usual injected medicine for anemia in people with kidney failure who are on dialysis. About 350 adults will take part to see if the pill can safely keep their red blood cell levels in a healthy range. The goal is to offer a more convenient treatment option.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anemia due to chronic disorder chronic renal failure syndrome end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANEMIA OF CHRONIC KIDNEY DISEASE

Contacts and locations

Locations

DaVita Research Site

Montgomery, Alabama, 36117-7306, United States
DaVita Research Site

Hartford, Connecticut, 06112-1260, United States
DaVita Research Site

Middlebury, Connecticut, 06705-3893, United States
DaVita Research Site

Columbus, Georgia, 31904-3604, United States
DaVita Research Site

Minneapolis, Minnesota, 55435-1807, United States
DaVita Research Site

Henderson, Nevada, 89052-5548, United States
DaVita Research Site

Las Vegas, Nevada, 89128-0804, United States
DaVita Research Site

El Paso, Texas, 79835-2200, United States
DaVita Research Site

Houston, Texas, 77054-3836, United States
DaVita Research Site

San Antonio, Texas, 78258-4800, United States
DaVita Research Site

The Woodlands, Texas, 77384-3024, United States
DaVita Research Site

Norfolk, Virginia, 23502-3235, United States
DaVita Research Site #1

Minneapolis, Minnesota, 55435-1807, United States
DaVita Research Site #1

El Paso, Texas, 79835-2200, United States
DaVita Research Site #1

Houston, Texas, 77054-3836, United States
DaVita Research Site #1

San Antonio, Texas, 78258-4800, United States
DaVita Research Site #1

Norfolk, Virginia, 23502-3235, United States
DaVita Research Site #2

San Antonio, Texas, 78258-4800, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.